A federal judge yesterday denied drug maker Novartis’ request to speed up a hearing on its request that the judge block the government from punishing the company over its denials of 340B pricing when health care providers use contract pharmacies

Judge Rejects Novartis’ Request to Speed Up Hearing in 340B Contract Pharmacy Lawsuit

A federal judge yesterday denied drug maker Novartis’ request to speed up a hearing on its request that the judge block the government from punishing the company over its denials of 340B pricing when health care providers use contract pharmacies.

Novartis is one of six drug companies suing the U.S. Health and Human Services Department over HHS’s findings in May that the companies’ denials of 340B discounts involving contract pharmacy are illegal and must be stopped immediately and remedied. On Wednesday, Sept. 22, HHS’s Health Resources and Services Administration (HRSA) referred all six companies to the HHS Office of Inspector General. OIG can impose hefty civil monetary penalties (CMPs) on manufacturers for knowingly and intentionally charging a 340B covered entity above the 340B ceiling price for a drug.

A federal judge yesterday denied drug maker Novartis’ request to speed up a hearing on its request that the judge block the government from punishing the company over its denials of 340B pricing when health care providers use contract pharmacies.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report